Walgreens Boots Alliance Inc (NASDAQ:WBA) – Research analysts at Jefferies Group raised their FY2019 EPS estimates for shares of Walgreens Boots Alliance in a note issued to investors on Wednesday. Jefferies Group analyst B. Tanquilut now anticipates that the pharmacy operator will post earnings per share of $6.64 for the year, up from their prior forecast of $6.06. Jefferies Group currently has a “Buy” rating and a $93.00 price objective on the stock.

Several other equities analysts also recently weighed in on WBA. Needham & Company LLC reissued a “buy” rating and set a $94.00 target price on shares of Walgreens Boots Alliance in a research report on Saturday, September 16th. Royal Bank of Canada began coverage on Walgreens Boots Alliance in a report on Tuesday, September 19th. They set an “outperform” rating and a $96.00 price objective for the company. Raymond James Financial restated a “market perform” rating on shares of Walgreens Boots Alliance in a report on Wednesday, September 27th. BidaskClub cut Walgreens Boots Alliance from a “sell” rating to a “strong sell” rating in a report on Tuesday, October 3rd. Finally, Zacks Investment Research upgraded Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a report on Thursday, October 5th. Nine equities research analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has issued a strong buy rating to the stock. The stock presently has an average rating of “Buy” and an average target price of $86.20.

Walgreens Boots Alliance (NASDAQ:WBA) traded up $0.69 during midday trading on Friday, hitting $76.07. The stock had a trading volume of 6,458,366 shares, compared to its average volume of 6,450,000. The company has a market cap of $75,340.00, a P/E ratio of 21.01, a P/E/G ratio of 1.28 and a beta of 1.22. The company has a current ratio of 0.96, a quick ratio of 0.47 and a debt-to-equity ratio of 0.48. Walgreens Boots Alliance has a 52-week low of $63.82 and a 52-week high of $88.00.

Walgreens Boots Alliance (NASDAQ:WBA) last released its earnings results on Thursday, January 4th. The pharmacy operator reported $1.28 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.27 by $0.01. The firm had revenue of $30.74 billion for the quarter, compared to the consensus estimate of $30.39 billion. Walgreens Boots Alliance had a return on equity of 19.15% and a net margin of 3.19%. The company’s revenue for the quarter was up 7.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.10 EPS.

Walgreens Boots Alliance announced that its Board of Directors has approved a share repurchase program on Wednesday, October 25th that authorizes the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization authorizes the pharmacy operator to buy shares of its stock through open market purchases. Stock repurchase programs are typically a sign that the company’s leadership believes its shares are undervalued.

In other Walgreens Boots Alliance news, Director John Anthony Lederer bought 20,000 shares of Walgreens Boots Alliance stock in a transaction that occurred on Thursday, October 26th. The shares were bought at an average cost of $67.00 per share, with a total value of $1,340,000.00. Following the transaction, the director now directly owns 50,000 shares of the company’s stock, valued at approximately $3,350,000. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director William C. Foote sold 2,736 shares of the company’s stock in a transaction dated Thursday, November 2nd. The shares were sold at an average price of $67.37, for a total value of $184,324.32. Following the transaction, the director now directly owns 16,415 shares in the company, valued at $1,105,878.55. The disclosure for this sale can be found here. Insiders own 14.80% of the company’s stock.

Large investors have recently made changes to their positions in the stock. Pathstone Family Office LLC increased its holdings in shares of Walgreens Boots Alliance by 226.6% in the second quarter. Pathstone Family Office LLC now owns 1,179 shares of the pharmacy operator’s stock valued at $1,969,000 after purchasing an additional 818 shares during the period. Hudock Capital Group LLC boosted its stake in shares of Walgreens Boots Alliance by 0.5% in the second quarter. Hudock Capital Group LLC now owns 1,306 shares of the pharmacy operator’s stock worth $102,000 after buying an additional 6 shares during the last quarter. Westside Investment Management Inc. boosted its stake in shares of Walgreens Boots Alliance by 10.4% in the second quarter. Westside Investment Management Inc. now owns 1,325 shares of the pharmacy operator’s stock worth $102,000 after buying an additional 125 shares during the last quarter. Zions Bancorporation boosted its stake in shares of Walgreens Boots Alliance by 983.3% in the third quarter. Zions Bancorporation now owns 1,365 shares of the pharmacy operator’s stock worth $105,000 after buying an additional 1,239 shares during the last quarter. Finally, Bristlecone Advisors LLC purchased a new stake in shares of Walgreens Boots Alliance in the third quarter worth about $135,000. 61.18% of the stock is currently owned by institutional investors.

TRADEMARK VIOLATION WARNING: “Equities Analysts Set Expectations for Walgreens Boots Alliance Inc’s FY2019 Earnings (WBA)” was originally published by Daily Political and is the property of of Daily Political. If you are viewing this news story on another domain, it was illegally copied and republished in violation of U.S. and international copyright & trademark laws. The legal version of this news story can be accessed at https://www.dailypolitical.com/2018/01/13/equities-analysts-set-expectations-for-walgreens-boots-alliance-incs-fy2019-earnings-wba.html.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Earnings History and Estimates for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.